IQVIA Holdings Inc. (FRA:QTS)

Germany · Delayed Price · Currency is EUR

140.70

-3.05 (-2.12%)

At close: Feb 20, 2026

-25.34% (1Y)

Market Cap	23.86B -33.3%
Revenue (ttm)	13.89B +5.9%
Net Income	1.16B -0.9%
EPS	6.68 +4.7%
Shares Out	n/a
PE Ratio	20.60
Forward PE	12.99
Dividend	n/a
Ex-Dividend Date	n/a

Volume	25
Average Volume	49
Open	143.45
Previous Close	143.75
Day's Range	139.85 - 143.75
52-Week Range	118.75 - 210.90
Beta	n/a
RSI	25.58
Earnings Date	Feb 5, 2026

About IQVIA Holdings

IQVIA Holdings Inc. provides clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and associated implementation services; real world solutions that enable life sciences and provider customers ... [Read more]

Industry Commercial Physical and Biological Research

CEO Ari Bousbib

Employees 93,000

Stock Exchange Frankfurt Stock Exchange

Ticker Symbol QTS

Full Company Profile

Financial Performance

In 2025, IQVIA Holdings's revenue was $16.31 billion, an increase of 5.87% compared to the previous year's $15.41 billion. Earnings were $1.36 billion, a decrease of -0.95%.

Financial numbers in USD Financial Statements